Medical Market Report

Global Contraceptive Drugs and Devices Market By Type (Oral, Vaginal, Injectable Contraceptive Drugs, and Male/Female Contraceptive Devices), By Application (Hospitals, Pharmacies, and Others), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 138401
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global Contraceptive Drugs and Devices Market is estimated to be valued US$ XX.X million in 2019. The report on Contraceptive Drugs and Devices Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global contraceptive drugs and devices market is segmented on the basis of Type, Application, and geography.

    In 2019, the North America market is valued US$ XX.X million and the market share is estimated X.X%, and it is expected to be US$ XX.X million and X.X% in 2029, with a CAGR X.X% from 2020 to 2029.

    Contraceptive Drugs and Devices Market Scope:

    By type, the market is segmented into Oral, Vaginal, Injectable Contraceptive Drugs, and Male/Female Contraceptive Devices. By Application, the market is divided into Hospitals, Pharmacies, and Others.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include Bayer Healthcare, Merck, Church & Dwight, Warmer Chilcott, Agile Therapeutics, Pfizer, BioSante Pharmaceuticals, Mayer Laboratories, Pantarhei Bioscience, and Teva Pharmaceutical Industries.

    Key Market Segments

    Type

    Oral

    Vaginal

    Injectable Contraceptive Drugs

    Male/Female Contraceptive Devices

    Application

    Hospitals

    Pharmacies

    Others

    Key Market Players included in the report:

    Bayer Healthcare

    Merck

    Church & Dwight

    Warmer Chilcott

    Agile Therapeutics

    Pfizer

    BioSante Pharmaceuticals

    Mayer Laboratories

    Pantarhei Bioscience

    Teva Pharmaceutical Industries

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and Contraceptive Drugs and Devices Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of Contraceptive Drugs and Devices Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers Contraceptive Drugs and Devices Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global Contraceptive Drugs and Devices Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the Contraceptive Drugs and Devices Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the Contraceptive Drugs and Devices Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of Contraceptive Drugs and Devices sub-markets, depending on key regions (various vital states).
    To analyze Contraceptive Drugs and Devices Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the Contraceptive Drugs and Devices Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide Contraceptive Drugs and Devices Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. Contraceptive Drugs and Devices Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope
    

    2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players
    

    3. Global Contraceptive Drugs and Devices Market Overview
    

    3.1. Contraceptive Drugs and Devices Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges
    

      3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy
    

    4. Global Contraceptive Drugs and Devices Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global Contraceptive Drugs and Devices Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Oral
    

      4.4. Vaginal
    

      4.5. Injectable Contraceptive Drugs
    

      4.6. Male/Female Contraceptive Devices
    

    5. Global Contraceptive Drugs and Devices Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global Contraceptive Drugs and Devices Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Hospitals
    

      5.4. Pharmacies
    

      5.5. Others
    

    6. Global Contraceptive Drugs and Devices Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America Contraceptive Drugs and Devices Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe Contraceptive Drugs and Devices Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific Contraceptive Drugs and Devices Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America Contraceptive Drugs and Devices Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa Contraceptive Drugs and Devices Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    

    7. Global Contraceptive Drugs and Devices Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. Bayer Healthcare
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments
    

      7.4. Merck
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments
    

      7.5. Church & Dwight
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments
    

      7.6. Warmer Chilcott
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments
    

      7.7. Agile Therapeutics
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments
    

      7.8. Pfizer
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments
    

      7.9. BioSante Pharmaceuticals
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments
    

      7.10. Mayer Laboratories
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments
    

      7.11. Pantarhei Bioscience
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments
    

      7.12. Teva Pharmaceutical Industries
    

        7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.